Results 191 to 200 of about 216,339 (397)
Bevacizumab Plus Fluorouracil: The Value of Being Part of a Developing Story [PDF]
, 2005 Alberto Sobrero, Paolo Bruzzi
openalex +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Extracranial malignant rhabdoid tumors (eMRT) are rare, highly aggressive pediatric neoplasms. While the liver is a relatively common anatomic site of presentation, the clinical course of patients with hepatic eMRT (eMRT‐L) is not well described.
Sebastian Bühner +16 more
wiley +1 more source
Pharmacokinetics of bevacizumab in haemodialysis [PDF]
, 2006 N. Garnier-Viougeat +7 more
openalex +1 more source
CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar +5 more
wiley +1 more source
Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma [PDF]
, 2006 Jason D. Wright +7 more
openalex +1 more source
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT Non‐small cell lung cancer (NSCLC) is often intrinsically resistant to several first‐ and second‐line therapeutics and can rapidly acquire further resistance after a patient begins treatment. Treatment outcomes are, therefore, significantly impacted by the optimization of scheduling.
Benjamin K. Schneider +2 more
wiley +1 more source
Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy [PDF]
, 2006 Brian I. Rini +5 more
openalex +1 more source
Renal cell carcinoma with atypical omental metastasis: A case report and literature review
UroPrecision, EarlyView.Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of ...
Andrew Jing +4 more
wiley +1 more source